BG
ANGO icon

BlackRock Group’s AngioDynamics ANGO Stock Holding History

BlackRock Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.06M Buy
63,000
+18,676
+42% +$311K ﹤0.01% 2105
2016
Q3 		$777K Buy
44,324
+5,931
+15% +$96.2K ﹤0.01% 2146
2016
Q2 		$552K Buy
38,393
+9,107
+31% +$114K ﹤0.01% 2227
2016
Q1 		$360K Buy
29,286
+3,003
+11% +$33.2K ﹤0.01% 2365
2015
Q4 		$319K Buy
26,283
+8,536
+48% +$105K ﹤0.01% 2373
2015
Q3 		$234K Buy
17,747
+2,137
+14% +$32.3K ﹤0.01% 2482
2015
Q2 		$256K Buy
15,610
+3,560
+30% +$59.1K ﹤0.01% 2513
2015
Q1 		$214K Sell
12,050
-1,221
-9% -$22.7K ﹤0.01% 2479
2014
Q4 		$252K Buy
13,271
+8,786
+196% +$149K ﹤0.01% 2449
2014
Q3 		$61K Buy
4,485
+3,430
+325% +$48.9K ﹤0.01% 2652
2014
Q2 		$17K Hold
1,055
– – ﹤0.01% 2780
2014
Q1 		$17K Hold
1,055
– – ﹤0.01% 2694
2013
Q4 		$18K Sell
1,055
-1,295
-55% -$19.9K ﹤0.01% 2607
2013
Q3 		$31K Buy
2,350
+1,295
+123% +$15.3K ﹤0.01% 2772
2013
Q2 		$12K Buy
+1,055
New +$11.2K ﹤0.01% 2545

Other funds holding ANGO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's ANGO Position: Q4 2016 in Review

BlackRock Group increased its AngioDynamics (ANGO) stake by 42% in Q4 2016, buying an estimated $311K and bringing the position to 63,000 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

BlackRock Group first reported a position in ANGO in Q2 2013 and has held it in 15 quarters since. 151 funds tracked by Wall St. Rank hold ANGO as of Q4 2016.

  • BlackRock Group held 63,000 shares of AngioDynamics worth $1.06M as of Q4 2016.
  • BlackRock Group bought 18,676 AngioDynamics shares in Q4 2016, an estimated $311K.
  • AngioDynamics made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2105 holding.
  • BlackRock Group first reported a position in AngioDynamics in Q2 2013 and has held it in 15 quarters since.
  • 151 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.